- Home
- ATLCP vs SNN Comparison
ATLCP vs SNN Comparison
Compare ATLCP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ATLCP
Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Current Price
Company Overview
Basic Information| Metric | ATLCP | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 417 | N/A |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | ATLCP | SNN |
|---|---|---|
| Price | $24.02 | $32.93 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | N/A | ★ 496.7K |
| Earning Date | N/A | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.78 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | ★ N/A | $58.80 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | N/A | $23.69 |
| 52 Week High | N/A | $38.79 |
Technical Indicators
Market Signals| Indicator | ATLCP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.69 | 46.72 |
| Support Level | $23.85 | $32.06 |
| Resistance Level | $24.20 | $33.60 |
| Average True Range (ATR) | 0.17 | 0.43 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 58.17 | 44.86 |
Price Performance
Historical ComparisonAbout ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.